Literature DB >> 1682395

Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults.

B E Sha1, A A Harris, C A Benson, W L Atkinson, P A Urbanski, J A Stewart, W W Williams, R L Murphy, J P Phair, S A Levin.   

Abstract

One hundred five asymptomatic human immunodeficiency virus-seropositive adults were screened for measles antibody. Ages ranged from 21 to 59 years (mean, 35.7). CD4+ lymphocyte counts (range, 76-1137/mm3), percentage of CD4+ cells (6-42), CD4:CD8 ratio (0.08-1.3), measles antibody titers by EIA, and undocumented history of prior measles or immunization were obtained. Forty-six patients gave a history of measles but no immunization, 18 of immunization but no measles, 26 of immunization and measles, and 15 of neither measles nor vaccination. Only one patient (less than 1%) lacked levels of antibody considered protective. Neither the presence nor the level of antibody were predictable from patient age, history of measles or immunization, CD4+ lymphocyte count, percentage of CD4+ cells, or CD4:CD8 ratio. Nearly all subjects had antibody to measles, regardless of immunization or measles history. Whether these antibodies are truly protective is unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682395     DOI: 10.1093/infdis/164.5.973

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA.

Authors:  P V Baskar; G D Collins; B A Dorsey-Cooper; R S Pyle; J E Nagel; D Dwyer; G Dunston; C E Johnson; N Kendig; E Israel; D R Nalin; W H Adler
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.

Authors:  Benjamin M Stermole; Greg A Grandits; Mollie P Roediger; Brychan M Clark; Anuradha Ganesan; Amy C Weintrob; Nancy F Crum-Cianflone; Tomas M Ferguson; Grace E Macalino; Michael L Landrum
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

3.  Decrease in Numbers of Naive and Resting B Cells in HIV-Infected Kenyan Adults Leads to a Proportional Increase in Total and Plasmodium falciparum-Specific Atypical Memory B Cells.

Authors:  Anne E Frosch; Oludare A Odumade; Justin J Taylor; Kathleen Ireland; George Ayodo; Bartholomew Ondigo; David L Narum; John Vulule; Chandy C John
Journal:  J Immunol       Date:  2017-05-19       Impact factor: 5.422

4.  Immunologic basis for revaccination of HIV-infected children receiving HAART.

Authors:  Kaitlin Rainwater-Lovett; William J Moss
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

5.  Surprisingly Low Levels of Measles Immunity in Persons With HIV: A Seroprevalence Survey in a United States HIV Clinic.

Authors:  Lindsey Rearigh; Jennifer O'Neill; Maureen Kubat; Harlan Sayles; Susan Swindells; Sara H Bares
Journal:  Open Forum Infect Dis       Date:  2020-09-12       Impact factor: 3.835

6.  Bone marrow is a major site of long-term antibody production after acute viral infection.

Authors:  M K Slifka; M Matloubian; R Ahmed
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.